JP Morgan Chase’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $485K | Buy |
34,300
+966
| +3% | +$11.2K | ﹤0.01% | 5055 |
|
|
2025
Q4 | $320K | Buy |
33,334
+6,471
| +24% | +$62K | ﹤0.01% | 5279 |
|
|
2025
Q3 | $253K | Buy |
26,863
+52
| +0.2% | +$497 | ﹤0.01% | 5393 |
|
|
2025
Q2 | $284K | Sell |
26,811
-10,334
| -28% | -$130K | ﹤0.01% | 5059 |
|
|
2025
Q1 | $558K | Sell |
37,145
-45,346
| -55% | -$754K | ﹤0.01% | 4695 |
|
|
2024
Q4 | $1.36M | Buy |
82,491
+66,982
| +432% | +$1.32M | ﹤0.01% | 4411 |
|
|
2024
Q3 | $383K | Sell |
15,509
-11,072
| -42% | -$287K | ﹤0.01% | 5081 |
|
|
2024
Q2 | $673K | Sell |
26,581
-794
| -3% | -$20.6K | ﹤0.01% | 4517 |
|
|
2024
Q1 | $695K | Sell |
27,375
-2,974
| -10% | -$72K | ﹤0.01% | 4590 |
|
|
2023
Q4 | $688K | Buy |
30,349
+16,017
| +112% | +$331K | ﹤0.01% | 4577 |
|
|
2023
Q3 | $267K | Sell |
14,332
-3,740
| -21% | -$77.6K | ﹤0.01% | 4874 |
|
|
2023
Q2 | $470K | Buy |
18,072
+3,136
| +21% | +$83.9K | ﹤0.01% | 4531 |
|
|
2023
Q1 | $428K | Buy |
14,936
+3,672
| +33% | +$109K | ﹤0.01% | 4601 |
|
|
2022
Q4 | $334K | Buy |
11,264
+658
| +6% | +$18.7K | ﹤0.01% | 4763 |
|
|
2022
Q3 | $253K | Buy |
10,606
+856
| +9% | +$19.7K | ﹤0.01% | 4836 |
|
|
2022
Q2 | $218K | Buy |
9,750
+1,198
| +14% | +$26.7K | ﹤0.01% | 5031 |
|
|
2022
Q1 | $215K | Sell |
8,552
-1,226
| -13% | -$37.4K | ﹤0.01% | 5151 |
|
|
2021
Q4 | $350K | Buy |
9,778
+3,142
| +47% | +$126K | ﹤0.01% | 5040 |
|
|
2021
Q3 | $282K | Sell |
6,636
-30
| -0.5% | -$1.24K | ﹤0.01% | 5052 |
|
|
2021
Q2 | $289K | Buy |
6,666
+339
| +5% | +$14.4K | ﹤0.01% | 5037 |
|
|
2021
Q1 | $259K | Sell |
6,327
-2,628
| -29% | -$99.7K | ﹤0.01% | 5040 |
|
|
2020
Q4 | $405K | Buy |
8,955
+1,012
| +13% | +$38.4K | ﹤0.01% | 4493 |
|
|
2020
Q3 | $272K | Buy |
7,943
+596
| +8% | +$21.5K | ﹤0.01% | 4230 |
|
|
2020
Q2 | $277K | Buy |
7,347
+153
| +2% | +$5.04K | ﹤0.01% | 4115 |
|
|
2020
Q1 | $207K | Sell |
7,194
-153
| -2% | -$6.19K | ﹤0.01% | 4254 |
|
|
2019
Q4 | $380K | Buy |
7,347
+748
| +11% | +$43.5K | ﹤0.01% | 4371 |
|
|
2019
Q3 | $362K | Sell |
6,599
-2
| -0% | -$103 | ﹤0.01% | 4323 |
|
|
2019
Q2 | $261K | Sell |
6,601
-17,324
| -72% | -$632K | ﹤0.01% | 4551 |
|
|
2019
Q1 | $723K | Buy |
23,925
+2,936
| +14% | +$101K | ﹤0.01% | 3993 |
|
|
2018
Q4 | $705K | Sell |
20,989
-42,540
| -67% | -$1.54M | ﹤0.01% | 3951 |
|
|
2018
Q3 | $2.68M | Buy |
63,529
+54,626
| +614% | +$2.16M | ﹤0.01% | 3252 |
|
|
2018
Q2 | $285K | Sell |
8,903
-12,820
| -59% | -$528K | ﹤0.01% | 4420 |
|
|
2018
Q1 | $1.08M | Sell |
21,723
-9,531
| -30% | -$538K | ﹤0.01% | 3635 |
|
|
2017
Q4 | $1.69M | Buy |
31,254
+14,395
| +85% | +$797K | ﹤0.01% | 3416 |
|
|
2017
Q3 | $982K | Buy |
16,859
+16,274
| +2,782% | +$851K | ﹤0.01% | 3530 |
|
|
2017
Q2 | $29K | Sell |
585
-33,913
| -98% | -$1.56M | ﹤0.01% | 4460 |
|
|
2017
Q1 | $1.5M | Sell |
34,498
-19,829
| -36% | -$947K | ﹤0.01% | 3201 |
|
|
2016
Q4 | $2.66M | Buy |
54,327
+42,817
| +372% | +$1.98M | ﹤0.01% | 2886 |
|
|
2016
Q3 | $551K | Buy |
11,510
+10,680
| +1,287% | +$528K | ﹤0.01% | 3375 |
|
|
2016
Q2 | $44K | Buy |
830
+602
| +264% | +$28.4K | ﹤0.01% | 4077 |
|
|
2016
Q1 | $10K | Hold |
228
| – | – | ﹤0.01% | 4240 |
|
|
2015
Q4 | $9K | Buy |
+228
| New | +$8.72K | ﹤0.01% | 4225 |
|
|
2014
Q1 | – | Sell |
-14,840
| Closed | -$566K | – | 3573 |
|
|
2013
Q4 | $566K | Buy |
+14,840
| New | +$458K | ﹤0.01% | 3428 |
|
Other funds holding ANIK
CP
VCM
BFM
CM
